. Puymirat, 2011 -Drug-eluting stents do we respect the on-label use in our daily practice

. Harry-martin-zimmerman, Progress in neuropathology. Grune & Stratton, 1971.

H. Tunstall-pedoe, D. Vanuzzo, M. Hobbs, M. Mähönen, Z. Cepaitis et al., Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations, The Lancet, vol.355, issue.9205, pp.688-700, 2000.
DOI : 10.1016/S0140-6736(99)11181-4

N. Danchin, E. Puymirat, N. Aissaoui, S. Adavane, and E. Durand, ??pid??miologie des syndromes coronaires aigus en France et en Europe, Annales de Cardiologie et d'Ang??iologie, vol.59, pp.37-41, 2010.
DOI : 10.1016/S0003-3928(10)70008-1

T. Mikkola, New evidence for cardiac benefit of postmenopausal hormone therapy, Climacteric, vol.80, issue.1, pp.5-10, 2017.
DOI : 10.1097/gme.0b013e3181f0839a

. Yusuf, Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study, The Lancet, vol.364, issue.9438, pp.937-52, 2004.
DOI : 10.1016/S0140-6736(04)17018-9

. Lewington, Age-specific relevance of usual blood pressure to vascular mortality, The Lancet, vol.361, issue.9366
DOI : 10.1016/S0140-6736(03)13064-4

M. Bertoluci and V. Rocha, Cardiovascular risk assessment in patients with diabetes, Diabetology & Metabolic Syndrome, vol.360, issue.24, 2017.
DOI : 10.1056/NEJMoa0805796

. Hess, Predicting target vessel revascularization in older patients undergoing percutaneous coronary intervention in the drug-eluting stent era, American Heart Journal, vol.167, issue.4, 2014.
DOI : 10.1016/j.ahj.2013.12.017

. Meliga, Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: a 3-year clinical outcome study. The Diabetes and Drug Eluting stent for LeFT main registry (D-DELFT), EuroIntervention, vol.4, issue.1, pp.77-83, 2008.
DOI : 10.4244/EIJV4I1A14

. Gould, Cholesterol Reduction Yields Clinical Benefit : Impact of Statin Trials, Circulation, vol.97, issue.10, 1998.
DOI : 10.1161/01.CIR.97.10.946

K. Ahn, High-density lipoprotein cholesterol (HDL-C) in cardiovascular disease: effect of exercise training, Integrative Medicine Research, vol.5, issue.3, 2016.
DOI : 10.1016/j.imr.2016.07.001

P. Libby, Inflammation in atherosclerosis, Nature, vol.103, issue.6917, pp.868-74, 2002.
DOI : 10.1074/jbc.274.45.32048

. Stary, -A definition of initial, fatty streak, and intermediate lesions in atherosclerosis, 1994.

H. Stary, A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis : A Report From the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association, Circulation, vol.92, issue.5, pp.1355-74, 1995.
DOI : 10.1161/01.CIR.92.5.1355

. Singh, Pathogenesis of atherosclerosis a multifactorial process, 2002.

. Finn, Le concept de la plaque d'athérome vulnérable ou instable, pp.4-196, 2011.

R. Krone, A simplified lesion classification for predicting success and complications of coronary angioplasty, The American Journal of Cardiology, vol.85, issue.10, pp.1179-84, 2000.
DOI : 10.1016/S0002-9149(00)00724-4

-. De-labriolle, Plaque d'athérome physiopathologie et évaluation -SFCardio http://www.sfcardio.fr/sites

S. Glagov, Compensatory Enlargement of Human Atherosclerotic Coronary Arteries, New England Journal of Medicine, vol.316, issue.22, pp.1371-1376, 1987.
DOI : 10.1056/NEJM198705283162204

P. Steg, Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Eur Heart J. 1 oct, vol.33, issue.20, pp.2569-619, 2012.

E. Eacts-, Guidelines on myocardial revascularization, 2014.

P. Serruys, Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease, New England Journal of Medicine, vol.360, issue.10, 2009.
DOI : 10.1056/NEJMoa0804626

. Tomasi, Revascularisation coronaire : quoi de neuf depuis Syntax ?, 2013.

P. Jerie, -Thirty years of the balloon catheter--A. Grüntzig and percutaneous balloon angioplasty, Cas Lek Cesk, vol.143, issue.12, pp.866-71, 2004.

G. Achkouty, Endoprothèses coronaires et angioplastie transluminale des artères coronaires, 2016.

A. Du, fixant les règles de classification des dispositifs médicaux, pris en application de l'article R, 2006.

H. Cnedimts, has-sante.fr/portail/upload/docs/application/pdf/2009- 12/brochure_presentation_cnedimts_02.pdf 54. HAS -Les critères d'évaluation de la CNEDiMTS

S. Ministère, . De, and . Santé, Comité économique des produits de santé, 2017.

A. Paca-, Nouveau contrat de bon usage des médicaments et produits et prestations, 2013.

L. Ministère-de and . Santé, de la jeunesse et des sports -La tarification à l'activité

. Omedit-haute-normandie, http://www.omedit-normandie.fr/media-files/note-explicative-audits-dmi-rapport-d-etape, 2016.

C. George, One-Year Follow-Up of The Stent Restenosis (STRESS I) Study 11This study was supported in part by Johnson & Johnson Interventional Systems (Cordis), Incorporated, Warren, New Jersey., The American Journal of Cardiology, vol.81, issue.7, pp.860-865, 1998.
DOI : 10.1016/S0002-9149(98)00004-6

. Macaya, 792-1 One Year Clinical Follow-up of the Benestent Trial, Journal of the American College of Cardiology, vol.25, issue.2, 1995.
DOI : 10.1016/0735-1097(95)93011-Z

. Nordmann, Clinical outcomes of primary stenting versus balloon angioplasty in patients with myocardial infarction: a meta-analysis of randomized controlled trials, The American Journal of Medicine, vol.116, issue.4
DOI : 10.1016/j.amjmed.2003.08.035

. Carrozza, Angiographic and clinical outcome of intracoronary, 1992.

. Roubin, Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty, Circulation, vol.85, issue.3, 1992.
DOI : 10.1161/01.CIR.85.3.916

. Yeh, Predicting the Restenosis Benefit of Drug-Eluting Versus Bare Metal Stents in Percutaneous Coronary Intervention, Circulation, vol.124, issue.14, 2011.
DOI : 10.1161/CIRCULATIONAHA.111.045229

. Rieu, Radial force of coronary stents : a comparative analysis Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv, mars, vol.46, issue.3, pp.380-91, 1999.

. Rieu, Assessment of the trackability, flexibility, and conformability of coronary stents: A comparative analysis, Catheterization and Cardiovascular Interventions, vol.346, issue.4, pp.496-503, 2003.
DOI : 10.1002/ccd.10583

URL : https://hal.archives-ouvertes.fr/hal-00092259

. Pache, Intracoronary stenting and angiographic results : strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial, 2003.
DOI : 10.1016/s1062-1458(03)00305-2

. Kastrati, Intracoronary stenting and angiographic results : strut thickness effect on restenosis outcome (ISAR-STEREO) trial, 2001.
DOI : 10.1161/01.cir.103.23.2816

. Barragan, Elastic recoil of coronary stents : a comparative analysis Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv, pp.112-121, 2000.

. Hindlet, Endoprothèses coronaires : critères de choix et évaluation d'une fiche technique type, 2005.

R. Köster, Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. The Lancet. 2 déc, pp.1895-1902, 2000.

D. Carrié, Évolution technologique des stents coronaires: où en est-on? Arch Mal Coeur Vaiss Prat, pp.9-14, 2014.

. Schächinger, A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts, ACC Current Journal Review, vol.13, issue.1, 2003.
DOI : 10.1016/j.accreview.2003.10.045

J. Juliard and P. Steg, La d??finition de la rest??nose vue par le clinicien??: aspects m??thodologiques et angiographiques, Pathologie Biologie, vol.52, issue.4
DOI : 10.1016/j.patbio.2004.02.001

. Serruys, Incidence of restenosis after successful coronary angioplasty : a timerelated phenomenon

. Cutlip, Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials, Journal of the American College of Cardiology, vol.40, issue.12, 2002.
DOI : 10.1016/S0735-1097(02)02597-4

URL : https://doi.org/10.1016/s0735-1097(02)02597-4

. Serruys, Incidence of restenosis after successful coronary angioplasty: a time- related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months, Circulation, vol.77, issue.2, pp.361-71, 1988.
DOI : 10.1161/01.CIR.77.2.361

. Holmes, Analysis of 1-year clinical outcomes in the SIRIUS trial, 2004.

. Muradi, Clinical presentation and predictors of target vessel revascularization after drug-eluting stent implantation, Cardiovascular Revascularization Medicine, vol.13, issue.6, 2012.
DOI : 10.1016/j.carrev.2012.10.003

. Kereiakes, Drug-eluting versus bare-metal stents. The Medical Roundtable Cardiovascular Edition. https://themedicalroundtable.com/article/drug-eluting-versus-bare-metal-stents

M. Maeng and H. Andersen, Rôle de l'adventice dans la resténose post-angioplastie coronaire, Sang Thromb Vaiss. 26 févr, vol.10, issue.1, pp.12-21, 1998.

. Serruys, A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods, The Lancet, vol.373, issue.9667, pp.897-910, 2009.
DOI : 10.1016/S0140-6736(09)60325-1

. Tobis, Assessment of Intermediate Severity Coronary Lesions in the Catheterization Laboratory, Journal of the American College of Cardiology, vol.49, issue.8, pp.839-887, 2007.
DOI : 10.1016/j.jacc.2006.10.055

. Cuisset, est-ce que la FFR ? Comment l'utiliser ? 2013. http://www.realites-cardiologiques.com/wp-content, 2013.

N. Pijls, Percutaneous Coronary Intervention of Functionally Nonsignificant Stenosis, Journal of the American College of Cardiology, vol.49, issue.21, pp.2105-2116, 2007.
DOI : 10.1016/j.jacc.2007.01.087

D. Bruyne, Fractional Flow Reserve???Guided PCI versus Medical Therapy in Stable Coronary Disease, New England Journal of Medicine, vol.367, issue.11
DOI : 10.1056/NEJMoa1205361

. Wijns, SFCardio -Angioplastie coronaire : les lésions résistantes, 2010.

A. Scai-, Guideline for Percutaneous Coronary intervention, 2011.

. Saito, 2014 -A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system : the CENTURY II trial

. Hlinomaz, Multivessel coronary disease diagnosed at the time of primary PCI for STEMI: Complete revascularisation versus conservative strategy

A. Banning and . Gershlick, AH -Management of multivessel coronary disease in STsegment elevation myocardial infarction, Curr Cardiol Rep, 2015.

. Kirtane, Safety and efficacy of drug-eluting and bare metal stents, 2009.

H. Win, Clinical outcomes and stent thrombosis following off-label use of drugeluting stents, JAMA. 9 mai, vol.297, issue.18, 2007.

. Brodie, Outcomes and Complications With Off-Label Use of Drug-Eluting Stents, JACC: Cardiovascular Interventions, vol.1, issue.4, pp.405-419, 2008.
DOI : 10.1016/j.jcin.2008.06.005

. Park, Five-year clinical outcomes of drug-eluting stents according to on-label and off-label use, The Korean Journal of Internal Medicine, vol.31, issue.4, 2016.
DOI : 10.3904/kjim.2015.045

. Doi, Impact of in-stent minimal lumen area at 9 months poststent implantation on 3-year target lesion revascularization-free survival, 2008.

. Kimura, Association of Intravascular Ultrasound- and Optical Coherence Tomography-Assessed Coronary Plaque Morphology With Periprocedural Myocardial Injury in Patients With Stable Angina Pectoris, Circulation Journal, vol.79, issue.9, pp.1944-53, 2015.
DOI : 10.1253/circj.CJ-14-1375